Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 9.00M
March 31, 2026 1.489B
December 31, 2025 -45.00M
September 30, 2025 -59.00M
June 30, 2025 7.00M
March 31, 2025 905.00M
December 31, 2024 348.00M
September 30, 2024 -50.00M
June 30, 2024 -1.00M
March 31, 2024 1.197B
December 31, 2023 -28.00M
September 30, 2023 -32.00M
June 30, 2023 -38.00M
March 31, 2023 1.89B
December 31, 2022 -49.00M
September 30, 2022 -7.00M
June 30, 2022 -61.00M
March 31, 2022 1.342B
December 31, 2021 56.00M
September 30, 2021 -19.00M
June 30, 2021 -63.00M
March 31, 2021 716.00M
December 31, 2020 196.00M
September 30, 2020 -12.00M
June 30, 2020 -46.00M
Date Value
March 31, 2020 631.00M
December 31, 2019 0.00
September 30, 2019 3.00M
June 30, 2019 2.00M
March 31, 2019 616.00M
December 31, 2018 2.051B
September 30, 2018 1.007B
June 30, 2018 7.514B
March 31, 2018 1.369B
December 31, 2017 465.00M
September 30, 2017 -60.00M
June 30, 2017 -59.00M
March 31, 2017 810.00M
December 31, 2016 1.763B
September 30, 2016 -41.00M
June 30, 2016 3.711B
March 31, 2016 332.00M
December 31, 2015 1.206B
September 30, 2015 976.00M
June 30, 2015 4.948B
March 31, 2015 295.00M
December 31, 2014 239.00M
September 30, 2014 -38.00M
June 30, 2014 -18.00M
March 31, 2014 244.00M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Biogen, Inc. -6.00M
Gilead Sciences, Inc. 346.00M
Regeneron Pharmaceuticals, Inc. 1.120B
Amgen, Inc. 0.00
REGENXBIO, Inc. -19.38M